130 related articles for article (PubMed ID: 18786779)
1. Use of concept of chemotherapy-equivalent biologically effective dose to provide quantitative evaluation of contribution of chemotherapy to local tumor control in chemoradiotherapy cervical cancer trials.
Plataniotis GA; Dale RG
Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1538-43. PubMed ID: 18786779
[TBL] [Abstract][Full Text] [Related]
2. Use of the concept of equivalent biologically effective dose (BED) to quantify the contribution of hyperthermia to local tumor control in radiohyperthermia cervical cancer trials, and comparison with radiochemotherapy results.
Plataniotis GA; Dale RG
Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1538-44. PubMed ID: 19306750
[TBL] [Abstract][Full Text] [Related]
3. Impact of tumor repopulation on radiotherapy planning.
Wang JZ; Li XA
Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):220-7. PubMed ID: 15629615
[TBL] [Abstract][Full Text] [Related]
4. Biologically effective dose-response relationship for breast cancer treated by conservative surgery and postoperative radiotherapy.
Plataniotis GA; Dale RG
Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):512-7. PubMed ID: 19625139
[TBL] [Abstract][Full Text] [Related]
5. How much radiation is the chemotherapy worth in advanced head and neck cancer?
Kasibhatla M; Kirkpatrick JP; Brizel DM
Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1491-5. PubMed ID: 17674979
[TBL] [Abstract][Full Text] [Related]
6. Dose-volume histogram parameters and local tumor control in magnetic resonance image-guided cervical cancer brachytherapy.
Dimopoulos JC; Lang S; Kirisits C; Fidarova EF; Berger D; Georg P; Dörr W; Pötter R
Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):56-63. PubMed ID: 19289267
[TBL] [Abstract][Full Text] [Related]
7. Preliminary estimation of treatment effect on uterine cervical squamous cell carcinoma in terms of tumor regression rate: comparison between chemoradiotherapy and radiotherapy alone.
Ohara K; Tanaka YO; Tsunoda H; Oki A; Satoh T; Onishi K; Kagei K; Sugahara S; Hata M; Igaki H; Tokuuye K; Akine Y; Yoshikawa H
Radiat Med; 2005 Feb; 23(1):25-9. PubMed ID: 15786748
[TBL] [Abstract][Full Text] [Related]
8. Five years' experience treating locally advanced cervical cancer with concurrent chemoradiotherapy and high-dose-rate brachytherapy: results from a single institution.
Parker K; Gallop-Evans E; Hanna L; Adams M
Int J Radiat Oncol Biol Phys; 2009 May; 74(1):140-6. PubMed ID: 18922646
[TBL] [Abstract][Full Text] [Related]
9. Chemoradiotherapy in the treatment of cervical cancer.
Eifel PJ
Semin Radiat Oncol; 2006 Jul; 16(3):177-85. PubMed ID: 16814159
[TBL] [Abstract][Full Text] [Related]
10. High-dose extended-field irradiation and high-dose-rate brachytherapy with concurrent chemotherapy for cervical cancer with positive para-aortic lymph nodes.
Kim YS; Kim JH; Ahn SD; Lee SW; Shin SS; Nam JH; Kim YT; Kim YM; Kim JH; Choi EK
Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1522-8. PubMed ID: 19231106
[TBL] [Abstract][Full Text] [Related]
11. Application of the linear-quadratic model to combined modality radiotherapy.
Bodey RK; Evans PM; Flux GD
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):228-41. PubMed ID: 15093920
[TBL] [Abstract][Full Text] [Related]
12. [Evidence based of chemoradiotherapy in cervix carcinoma].
Joly-Lobbedez F
Cancer Radiother; 2009 Oct; 13(6-7):503-6. PubMed ID: 19695934
[TBL] [Abstract][Full Text] [Related]
13. Clinical outcome for chemoradiotherapy in carcinoma of the cervix.
Spensley S; Hunter RD; Livsey JE; Swindell R; Davidson SE
Clin Oncol (R Coll Radiol); 2009 Feb; 21(1):49-55. PubMed ID: 19081712
[TBL] [Abstract][Full Text] [Related]
14. A feasibility study of topotecan with standard-dose cisplatin and concurrent primary radiation therapy in locally advanced cervical cancer.
Gatcliffe TA; Tewari KS; Shah A; Brewster WR; Burger RA; Kuo JV; Monk BJ
Gynecol Oncol; 2009 Jan; 112(1):85-9. PubMed ID: 18977518
[TBL] [Abstract][Full Text] [Related]
15. The potential for mathematical modelling in the assessment of the radiation dose equivalent of cytotoxic chemotherapy given concomitantly with radiotherapy.
Jones B; Dale RG
Br J Radiol; 2005 Oct; 78(934):939-44. PubMed ID: 16177018
[TBL] [Abstract][Full Text] [Related]
16. [Cancer of the uterine cervix: combination of radiotherapy and cisplatin chemotherapy (chemoradiotherapy) is superior to radiotherapy alone in local advanced stages].
Mazeron JJ
Bull Cancer; 1999 Mar; 86(3):247-8. PubMed ID: 10847719
[No Abstract] [Full Text] [Related]
17. Intra-arterial infusion chemotherapy using cisplatin with radiotherapy for Stage III squamous cell carcinoma of the cervix.
Kaneyasu Y; Nagai N; Nagata Y; Hashimoto Y; Yuki S; Murakami Y; Kenjo M; Kakizawa H; Toyota N; Fujiwara H; Kudo Y; Ito K
Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):369-77. PubMed ID: 19735865
[TBL] [Abstract][Full Text] [Related]
18. Neoadjuvant chemotherapy followed by concurrent hyperfractionated radiation therapy and sensitizing chemotherapy for locally advanced (T3-T4) oropharyngeal squamous cell carcinoma.
Finnegan V; Parsons JT; Greene BD; Sharma V
Head Neck; 2009 Feb; 31(2):167-74. PubMed ID: 18853443
[TBL] [Abstract][Full Text] [Related]
19. High-dose rate brachytherapy using inverse planning simulated annealing for locoregionally advanced cervical cancer: a clinical report with 2-year follow-up.
Kim DH; Wang-Chesebro A; Weinberg V; Pouliot J; Chen LM; Speight J; Littell R; Hsu IC
Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1329-34. PubMed ID: 19409728
[TBL] [Abstract][Full Text] [Related]
20. Effect of intravenously administered iron sucrose on the prevention of anemia in the cervical cancer patients treated with concurrent chemoradiotherapy.
Kim YT; Kim SW; Yoon BS; Cho HJ; Nahm EJ; Kim SH; Kim JH; Kim JW
Gynecol Oncol; 2007 Apr; 105(1):199-204. PubMed ID: 17234260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
